Brandywine Managers, LLC Neurocrine Biosciences Inc Transaction History

Brandywine Managers, LLC

  • $94.1 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$86.91 - $108.33 $234,657 - $292,491
-2,700 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$69.31 - $91.53 $62,379 - $82,377
-900 Reduced 25.0%
2,700 $238,000
Q4 2018

Feb 12, 2019
BUY
$68.32 - $124.36 $245,951 - $447,696
3,600 New
3,600 $257,000

Others Institutions Holding NBIX

# of Institutions
622
Shares Held
95.2M
Call Options Held
661K
Put Options Held
221K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Brandywine Managers, LLC Portfolio

Follow Brandywine Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Managers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email